William Fearon
Director, Interventional Cardiology, Stanford University Medical Center · Stanford Health Care
Credentials: · · · ·
History
- Present
- Present
- Present
- 2002–2003
Interventional Cardiology
1999–2002- 1994–1995
1986–1990
Research
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
New England Journal of Medicine · 2016 · 4,142 citations
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
New England Journal of Medicine · 2009 · 3,303 citations
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease
New England Journal of Medicine · 2012 · 2,153 citations
83 papers
53 papers · 9 as a fellow
36 papers
34 papers · 2 as a resident
34 papers
- TN
31 papers · 5 as a fellow
28 papers · 4 as a fellow
28 papers
Grants
- 2025–2030
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.5M · Stanford University
- 2019–2026
PCSK9 Inhibition After Heart Transplantation
National Heart, Lung, and Blood Institute · R33
Contact PI · $1.8M · Stanford University
- 2019–2020
PCSK9 Inhibition After Heart Transplantation
National Heart, Lung, and Blood Institute · R61
Contact PI · $435.5K · Stanford University
- 2009–2016
ACE Inhibition and Cardiac Allograft Vasculopathy
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · Stanford University
Clinical trials
- 2023–2026
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
Principal investigator · Active not recruiting
CathWorks Ltd.
- 2019–2025
Cardiac Allograft Vasculopathy Inhibition With Alirocumab
Principal investigator · Completed · Phase 2
Stanford University
- 2015–2017
Principal investigator · Unknown
Acist Medical Systems
- 2009–2015
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Principal investigator · Completed
Stanford University